These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 24123110

  • 1. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters.
    Guañabens N, Mumm S, Möller I, González-Roca E, Peris P, Demertzis JL, Whyte MP.
    J Bone Miner Res; 2014 Apr; 29(4):929-34. PubMed ID: 24123110
    [Abstract] [Full Text] [Related]

  • 2. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia.
    Sutton RA, Mumm S, Coburn SP, Ericson KL, Whyte MP.
    J Bone Miner Res; 2012 May; 27(5):987-94. PubMed ID: 22322541
    [Abstract] [Full Text] [Related]

  • 3. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP, McAlister WH, Mumm S, Bierhals AJ.
    Bone; 2019 May; 122():231-236. PubMed ID: 30825650
    [Abstract] [Full Text] [Related]

  • 4. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B6 metabolism.
    Whyte MP, Zhang F, Mack KE, Wenkert D, Gottesman GS, Ericson KL, Cole JT, Coburn SP.
    Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypophosphatasia: An overview For 2017.
    Whyte MP.
    Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
    [Abstract] [Full Text] [Related]

  • 7. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.
    Whyte MP, Zhang F, Wenkert D, Mumm S, Berndt TJ, Kumar R.
    Bone; 2020 May; 134():115300. PubMed ID: 32112990
    [Abstract] [Full Text] [Related]

  • 8. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients.
    Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL, Mumm S.
    Bone; 2015 Jun; 75():229-39. PubMed ID: 25731960
    [Abstract] [Full Text] [Related]

  • 9. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.
    Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Bürgi S, Sergi C, Ryan L, Ericson KL, Whyte MP, Högler W.
    Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561
    [Abstract] [Full Text] [Related]

  • 10. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
    Whyte MP, Coburn SP, Ryan LM, Ericson KL, Zhang F.
    Bone; 2018 May; 110():96-106. PubMed ID: 29360619
    [Abstract] [Full Text] [Related]

  • 11. Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia.
    Whyte MP, Wenkert D, McAlister WH, Mughal MZ, Freemont AJ, Whitehouse R, Baildam EM, Coburn SP, Ryan LM, Mumm S.
    J Bone Miner Res; 2009 Aug; 24(8):1493-505. PubMed ID: 19335222
    [Abstract] [Full Text] [Related]

  • 12. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP.
    J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
    [Abstract] [Full Text] [Related]

  • 13. Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health.
    Lin EL, Gottesman GS, McAlister WH, Bijanki VN, Mack KE, Griffin DM, Mumm S, Whyte MP.
    Bone; 2020 Jul; 136():115322. PubMed ID: 32200022
    [Abstract] [Full Text] [Related]

  • 14. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.
    Whyte MP.
    Nat Rev Endocrinol; 2016 Apr; 12(4):233-46. PubMed ID: 26893260
    [Abstract] [Full Text] [Related]

  • 15. Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review).
    Wenkert D, McAlister WH, Coburn SP, Zerega JA, Ryan LM, Ericson KL, Hersh JH, Mumm S, Whyte MP.
    J Bone Miner Res; 2011 Oct; 26(10):2389-98. PubMed ID: 21713987
    [Abstract] [Full Text] [Related]

  • 16. [Tissue-nonspecific alkaline phosphatase and hypophosphatasia].
    Oda K, Kinjoh NN, Sohda M, Komaru K, Amizuka N.
    Clin Calcium; 2014 Feb; 24(2):233-9. PubMed ID: 24473356
    [Abstract] [Full Text] [Related]

  • 17. Adult hypophosphatasia treated with teriparatide.
    Whyte MP, Mumm S, Deal C.
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1203-8. PubMed ID: 17213282
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypophosphatasia: Vitamin B6 status of affected children and adults.
    Whyte MP, Zhang F, Wenkert D, Mack KE, Bijanki VN, Ericson KL, Coburn SP.
    Bone; 2022 Jan; 154():116204. PubMed ID: 34547524
    [Abstract] [Full Text] [Related]

  • 20. Hypophosphatasia: Natural history study of 101 affected children investigated at one research center.
    Whyte MP, Wenkert D, Zhang F.
    Bone; 2016 Dec; 93():125-138. PubMed ID: 27576207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.